Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer
Clinical trial NCT07173387 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07173387
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2028-10-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.